Navigation Links
Omeros Chosen to Present at NewsMakers in the Biotech Industry 2013 Conference
Date:9/20/2013

SEATTLE, Sept. 20, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the NewsMakers in the Biotech Industry 2013 Conference in New York City next week.  The presentation is scheduled for Friday, September 27, 2013 at 2:00 p.m. EDT.

The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the Company's website at www.omeros.com.  

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates, OMS302 for lens replacement surgery and OMS103HP for arthroscopy, are derived from its proprietary PharmacoSurgery® platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has six clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the pharmaceutical industry. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.

Contact:
Jennifer Cook Williams
Cook Williams Communications, Inc.
Inve
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Omeros Reports Initiation of Phase 2 Clinical Trial with OMS824
2. Omeros Reports Additional Positive Results from OMS824 Program
3. Omeros Submits OMS302 Marketing Authorization Application to European Medicines Agency
4. Omeros to Present at the Stifel Healthcare Conference 2013
5. Michael A. Jacobsen Joining Omeros as Vice President, Finance and Chief Accounting Officer
6. Omeros Corporation Reports Second Quarter 2013 Financial Results
7. Omeros to Present at the Wedbush 2013 Life Sciences Management Access Conference
8. Omeros Submits New Drug Application to U.S. FDA for OMS302
9. Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial
10. Omeros Files Clinical Trial Application for Lead Antibody in MASP-2 Program
11. Omeros Corporation Reports First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... SAN DIEGO , July 25, 2014  Arena ... it will provide a corporate update and report second ... Market opens on Friday, August 1, 2014. That same ... at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). ... by dialing 877.643.7155 for domestic callers and 914.495.8552 for ...
(Date:7/24/2014)... PARK, Kan. , July 24, 2014 /PRNewswire/ ... of two compounds that will be added to ... with Australian-based CIMTECH Pty Ltd, a biotechnology company. ... PAR 122 have shown promise in bone regeneration ... license to develop the compounds for the veterinary ...
(Date:7/24/2014)... , Deutschland, und MARSEILLE ... , Weltweite Exklusivlizenz ... ermöglicht QIAGEN die Entwicklung von Tests auf ... Blutkrebs  Neuer Test weist Mutationen ... Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf vermuten ...
Breaking Medicine Technology:Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
... Corporation (NYSE: GPX ), a global ... technical training, e-Learning solutions, management consulting and engineering services, ... Esposito-Mayer will speak at the ROTH Capital Partners 24th ... PT. The conference will be held at The Ritz ...
... and NEW YORK, March 6, 2012   Access ... leveraging its proprietary drug-delivery platforms to develop treatments in ... lead product website, www.MuGard.com , with a new ... visit the Testimonials section of the MuGard site or ...
Cached Medicine Technology:Access Pharmaceuticals Updates MuGard.com With New Product Testimonial 2Access Pharmaceuticals Updates MuGard.com With New Product Testimonial 3
(Date:7/25/2014)... (PRWEB) July 25, 2014 Consuming too ... How to know? , Read the labels! , Learn ... determine how it relates to health during a "Healthy ... Aug. 1 at Humility House, 755 Ohltown Road, Austintown. ... lead an informational discussion and answer questions. , ...
(Date:7/25/2014)... City, UT (PRWEB) July 25, 2014 ... court surfaces for the recent Nike National Invitational ... the current United States Junior National Tournament (USJN) ... July 25. , The flooring for these prestigious national ... more than 300,000 square feet of playing surface at ...
(Date:7/25/2014)... 2014 As reported by People Magazine in ... Jersey Shore and Getting Sober (7/15), one of the ... has spoken out to the public about his personal transformation. ... The Situation admits that moving on with his life was ... and other drugs in 2012 and even spent some time ...
(Date:7/25/2014)... July 25, 2014 (HealthDay News) -- The human brain ... of dehydration, a new study finds. Although ... in England have found that the brain compensates by ... blood. "This research has helped us understand a ... extreme exercise in extreme conditions," study first author Steven ...
(Date:7/25/2014)... Art of Facial Surgery has recently stepped up ... who are looking for minor touch-ups to make them more ... American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) ... surgery showed a surprising increase between 2012 and 2013. ... transplants increased by 7 percent and eyelid surgery increased by ...
Breaking Medicine News(10 mins):Health News:Learn to Decipher Food Labels at Humility House 2Health News:Sport Court Provides All Sports Flooring for Basketball Events in Chicago and Washington D.C. 2Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 3
... , , , ... Dr. Raymond Boyle, Ph.D., M.P.H., will be the new Director of ... and Epidemiology from the University of Oregon and the University of ... this new addition to ClearWay Minnesota and our research department," said ...
... explain why some function fine on six hours a night , ... by just fine on six hours of sleep, and a new ... finding doesn,t appear likely to help people with insomnia. Still, it ... long as they do, said study co-author Ying-Hui Fu, a professor ...
... Aug. 13 The following statement was released today by United ... comprehensive health care has been a high priority for the disability ... Act (H.R. 3200) will make significant strides toward meeting that goal. ... , Major insurance market reforms such as ...
... , BASKING RIDGE, N.J., Aug. 13 ... record-keeping, protecting confidential patient information becomes vastly more complex. ... designed to help safeguard the growing exchange of electronic patient ... , The first offering, Verizon Security Management ...
... , , , , ... busy preparing their children for departure for school, it is just ... from bringing bed bugs home from college and their travels. ... in the New York Metropolitan area, has seen a significant increase ...
... , MIAMI BEACH, Fla., Aug. 13 Centers ... facilities in Florida at the Florida Health Care Conference in Hollywood, ... for pressure ulcer management from the Florida Agency for Health Care ... Weaver, Chief of Field Operations, Division of Managed Care and Health ...
Cached Medicine News:Health News:They Snooze Less, But They Don't Lose 2Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 2Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 3Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 4Health News:Bed Bug Epidemic and Upcoming School Breaks Could Wreak Havoc on Homeowners 2Health News:Bed Bug Epidemic and Upcoming School Breaks Could Wreak Havoc on Homeowners 3Health News:Centers of Excellence Awards Presented to Over 100 Nursing Facilities as Nursing Facilities Reach the 'Tipping Point' in Treating Pressure Ulcers 2
... knee manufacturers focus attention on implant design, ... The Profix Total Knee System seeks to ... implant system and the tools to implant ... widely recognized for innovation in total knee ...
Cruciate retaining, posterior stabilized and constrained components....
Cruciate retaining, posterior stabilized and constrained components....
Maximum contact. Minimum wear. Outstanding results....
Medicine Products: